NEW YORK (TheStreet) -- Here are 10 things you should know for Wednesday, Sept. 24:
1. -- U.S. stock futures were pointing higher Wednesday following three straight days of losses on Wall Street.
European stocks were mixed amid a drop in German business confidence. Asian indices ended the trading session mixed.
2. -- The economic calendar in the U.S. on Wednesday includes new home sales for August at 10 a.m. EDT.
3. -- U.S. stocks on Tuesday fell for a third day as U.S. fighter jets attacked strongholds of the Islamic State, Europe showed signs of economic weakness and the U.S. government announced tougher rules on corporate inversion deals.
The Dow Jones Industrial Average
Must Read: Warren Buffett's Top 10 Dividend Stocks
4. -- Citizens Financial Group (CFG) raised about $3 billion in its initial public offering that was priced at $21.50 a share, below the expected range.
The U.S. banking unit of Royal Bank of Scotland (RBS) said late Tuesday that it sold 140 million shares in the IPO that had initially been expected to fetch between $23 to $25 a share.
The stock will begin trading Wednesday on the New York Stock Exchange.
Citizens, based in Providence, R.I., has about 1,200 branches across the Northeast and Midwest.
Citizens said it expects RBS to remain a majority owner of its common stock and have "significant control" of its business.
5. -- Pacific Investment Management Co. is being investigated by the Securities and Exchange Commission into whether the bond giant artificially boosted the returns of a popular fund aimed at small investors, The Wall Street Journal reported, citing people familiar with the matter.
A probe into pricing issues at Pimco has been under way for some months, the people familiar with the matter told the newspaper. Bill Gross, Pimco's co-founder, has been interviewed by SEC investigators, the people said. Gross declined to comment for the Journal article.
The issues being scrutinized by the SEC include the way the Pimco Total Return ETF BOND, managed by Gross, purchased and valued certain bonds, the Journal reported.
6. -- Pfizer (PFE) explored a potential tax-lowering takeover of Dublin-based rival Actavis in recent weeks, but talks between the two pharmaceutical companies have ended, the Journal reported, citing to a person familiar with the matter.
Pfizer approached Actavis proposing a cash-and-stock tie-up, according to the person. The talks ended last week after Actavis decided against a deal, the person told the Journal.
The Journal noted the Actavis talks marked the second attempt this year by Pfizer to pursue an acquisition that would have lowered its U.S. taxes -- it made an unsuccessful $120 billion offer for the U.K.'s AstraZeneca (AZN) earlier this year.
Revenue in the quarter was $2.94 billion, ahead of estimates of $2.9 billion.
The home furnishings retailer said it expects to earn between $5 to $5.08 a share for the full year; analysts estimates full-year earnings of $4.80 a share.
Must Read: 10 Stocks George Soros Is Buying